JMBA News Alert Jamba Inc (JMBA) 13.39 12/17/2014 02:35:17

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Jamba Inc (JMBA) 13.39 $JMBA

Jamba preps for refranchising push
Seeking Alpha - at Seeking Alpha - Mon Dec 08, 10:47AM CST

JMBA: 13.39 (-0.18)

Jamba Juice Engages Peak Franchise Capital to Lead Refranchising Efforts
Business Wire - Mon Dec 08, 7:30AM CST
Jamba Inc. (NASDAQ:JMBA), a leading health and wellness brand and the leading retailer of freshly squeezed juice, today announced that the Company has engaged Peak Franchise Capital, a leading advisory firm focused on the restaurant industry, to lead its recently-announced refranchising effort. Jamba announced in November plans to refranchise up to 114 stores during the first half of 2015, while also focusing on growth initiatives and reducing expenses.
JMBA: 13.39 (-0.18)

Jamba, Inc. Adopts Rule 10b5-1 Plan in Conjunction with Share Repurchase Program
Business Wire - Mon Dec 08, 7:30AM CST
Jamba, Inc. (NASDAQ:JMBA), a leading health and wellness brand and the leading retailer of freshly squeezed juice, today announced that it adopted a Rule 10b5-1 share repurchase plan under the Securities Exchange Act of 1934 (the "Plan" in connection with its $25 million share repurchase authorization approved by the Company's board of directors and previously announced on November 4, 2014.
JMBA: 13.39 (-0.18)

JCP Investment Management wants board shakeup at Jamba
Seeking Alpha - at Seeking Alpha - Fri Dec 05, 1:02PM CST

JMBA: 13.39 (-0.18)

Jamba Juice Provides Update on Initiatives to Drive Growth and Enhance Shareholder Value
Business Wire - Thu Dec 04, 7:30AM CST
--Completes Implementation of Cost Savings Designed to Reduce G&A Expense to $30 Million Annually
JMBA: 13.39 (-0.18)

Jamba Juice Spreads Healthy Holiday Cheer with Launch of New eGifting Capability and Return of its Special Gift Card Promotion
PR Newswire - Wed Nov 19, 8:15AM CST
Jamba Juice Company (NASDAQ; JMBA), a leading healthy, active lifestyle brand, is excited to announce the launch of Jamba® eGifting - a convenient and easy way for customers to purchase Jamba Juice gift cards online. Jamba eGifters can now choose from a selection of new exclusive digital designs, select an amount, personalize a message, and digitally share a nutritious gift with family and friends all year long in the form of an electronic gift card.
JMBA: 13.39 (-0.18)

Jamba: The Good, The Bad And The Unknown
Paolo Gorgo - Seeking Alpha - Tue Nov 11, 2:37PM CST
Last week Jamba (NASDAQ: JMBA ) reported Q3 2014 numbers. Revenues of $58.28M missed consensus by $1M, and EPS on a non-GAAP basis of $0.03 missed analysts' expectations by a large number, $0.28. GAAP EPS were a loss of $(0.10), compared to...
JMBA: 13.39 (-0.18)

Jamba (JMBA) Downgraded From Buy to Hold
at The Street - Thu Nov 06, 8:23AM CST
Jamba (JMBA) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C-.
JMBA: 13.39 (-0.18)

CORRECTING and REPLACING Jamba, Inc. Announces $25 Million Share Repurchase Program
Business Wire - Wed Nov 05, 1:33PM CST
Please replace the release dated November 4, 2014 with the following corrected version due to multiple revisions.
JMBA: 13.39 (-0.18)

Jamba's (JMBA) CEO James White on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 9:30PM CST

JMBA: 13.39 (-0.18)

Jamba reports 3Q loss
Automated Insights - Tue Nov 04, 5:39PM CST
EMERYVILLE, Calif. (AP) _ Jamba Inc. (JMBA) on Tuesday reported a third-quarter loss of $1.7 million.
JMBA: 13.39 (-0.18)

More on Jamba's Q3
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 5:37PM CST

JMBA: 13.39 (-0.18)

Jamba (JMBA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 3:55PM CST

JMBA: 13.39 (-0.18)

Jamba misses by $0.28, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:19PM CST

JMBA: 13.39 (-0.18)

Jamba announces new $25B buyback plan
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 3:03PM CST

JMBA: 13.39 (-0.18)

Jamba, Inc. Announces Third Quarter 2014 Financial Results and Update on Strategic Initiatives
Business Wire - Tue Nov 04, 3:01PM CST
--Re-franchising and Cost-Saving Efforts Are Accelerated
JMBA: 13.39 (-0.18)

Jamba, Inc. Announces $25 Million Share Repurchase Program
Business Wire - Tue Nov 04, 3:00PM CST
Jamba, Inc. (NASDAQ:JMBA), a leading healthy, active lifestyle brand announced today that its Board of Directors approved the terms of a share repurchase plan. Pursuant to the program, the Company is authorized to repurchase up to $25 million of its common stock beginning November 10, 2014 and ending June 10, 2016, subject to the Company's pre-existing blackout periods.
JMBA: 13.39 (-0.18)

Jamba, Inc. Announces Refranchising Initiative Involving Up to 114 Company Stores in the California Market
Business Wire - Tue Nov 04, 3:00PM CST
Jamba, Inc. (NASDAQ:JMBA), a leading healthy, active lifestyle brand, announced today the launch of an accelerated refranchising initiative in the California market that is expected to involve approximately 114 Jamba Juice store locations.
JMBA: 13.39 (-0.18)

Notable earnings after Tuesday's close
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:35PM CST

AMRS: 2.14 (-0.01), ITRI: 39.59 (+0.27), AWAY: 28.28 (-1.07), OKE: 44.30 (-0.02), HR: 26.73 (-0.01), NYMT: 7.89 (+0.02), OCLR: 1.92 (+0.03), ENPH: 12.46 (+0.08), ADEP: 8.00 (-0.03), CBSO: 27.51 (+0.58), NSTG: 13.56 (-0.25), MITT: 18.13 (-0.76), CRTO: 37.84 (+0.53), FOXA: 36.21 (-0.29), OKS: 38.23 (-0.16), JMBA: 13.39 (-0.18), IVR: 15.31 (-0.18), CSU: 24.03 (-0.29), MYGN: 33.02 (-0.41), JIVE: 5.33 (-0.03), GAS: 50.42 (-0.23), COUP: 15.39 (+0.08), NRP: 9.59 (+1.19), MOSY: 1.65 (-0.03), COHR: 58.60 (-0.05), DOX: 45.78 (-0.12), CKEC: 24.91 (-0.59), OAS: 14.23 (+2.01), PAYC: 26.59 (+2.35), PCYC: 129.56 (+1.12), AXLL: 37.22 (-1.06), NP: 56.01 (-0.32), BIRT: 6.57 (+0.02), ATVI: 19.38 (-0.64), EXAM: 38.20 (-0.96), P: 16.90 (-0.29), JAZZ: 159.65 (-2.95), PBPB: 11.88 (+0.22), EXEL: 1.31 (-0.05), CERS: 4.78 (+0.14), DVN: 54.10 (+1.44), FEYE: 27.72 (-0.84), CHUY: 19.04 (-0.78), FRGI: 55.82 (-4.46), GHDX: 30.54 (+0.01), PACD: 4.46 (-0.04), BIO: 116.03 (+0.28), BIOL: 2.63 (-0.04), JKHY: 61.39 (-0.36), KAR: 33.79 (-0.35), CDXS: 2.28 (-0.04), MPO: 1.42 (+0.26), FANG: 55.84 (+2.44), CORT: 3.09 (+0.12), CALD: 14.76 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 154

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 27

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 129

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 150

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading

Top 5 Most Recently Viewed Articles

Coca-Cola's Emerging Markets Strategy Fuels Long-Term Growth

Updated Category News Views 929

Coca-Cola's Position in Emerging Markets Coca-Cola Co (NYSE: KO) stands as a beacon of growth, with a visionary strategy that highlights both immediate and long-term opportunities. The company has successfully positioned itself in vital markets, particularly in North America and Latin America, which have proven central to its success. According to recent insights from...

Continue Reading
Voda IQ Appoints Armando Piccinini to Drive European Sales

Updated Category News Views 121

Voda IQ dropped some big news back in 2024 when they appointed Armando Piccinini as their European Sales Director. This guy’s got over twenty years under his belt in aquatic conservation, which they clearly hope will ramp up their sales strategy across Europe. But you gotta wonder—are the numbers behind this move really there? Can Experience Translate to Sales Growth?...

Continue Reading
Magnera Corporation to Shine at Upcoming Finance Conference

Updated Category News Views 163

Magnera Corporation's Conference Participation Announcement Magnera Corporation (NYSE: MAGN) has made an exciting announcement regarding its upcoming participation in a significant financial event. The company is set to be a part of the 2025 Bank of America Leveraged Finance Conference, aimed at fostering connections with top institutional investors. The event will take...

Continue Reading
Bullish Momentum Unveiled: Insights on Merck & Co Stocks

Updated Category News Views 180

Exciting Developments in Merck & Co Options Activity Notable investors are expressing strong optimism about Merck & Co. A recent analysis of options trading strategies reveals a wave of activity among traders aiming to capitalize on this potential. Options Trading Overview When reviewing the options history for Merck & Co (NYSE: MRK), we found a total of 33 trades that...

Continue Reading
Gilead Snags Arcellx: A High-Stakes Cancer Gamble Unfolds

Updated Category News Views 195

The Big Play for Cancer Innovation Gilead Sciences Inc. (NASDAQ:GILD) pulled the trigger on a pretty huge acquisition deal, landing Arcellx Inc. (NASDAQ:ACLX) this past Monday for a staggering $115 per share, which gets better with a potential extra $5 per share on a contingent value right. That rings in a hefty total of $7.8 billion—no pocket change, folks. What’s...

Continue Reading